Antigen Information
General Information of This Antigen
| Antigen ID | TAR0KVKEF |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | HLA class II histocompatibility antigen gamma chain (CD74) |
|||||
| Gene Name | CD74 |
|||||
| Synonym | DHLAG; HLA-DR antigens-associated invariant chain;Ia antigen-associated invariant chain;CD_antigen=CD74 |
|||||
| Sequence |
MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLL
LAGQATTAYFLYQQQGRLDKLTVTSQNLQLENLRMKLPKPPKPVSKMRMATPLLMQALPM GALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLP LQCYGSIGYCWCVFPNGTEVPNTRSRGHHNCSESLELEDPSSGLGVTKQDLGPVPM Click to Show/Hide
|
|||||
| Function |
Plays a critical role in MHC class II antigen processing by stabilizing peptide-free class II alpha/beta heterodimers in a complex soon after their synthesis and directing transport of the complex from the endoplasmic reticulum to the endosomal/lysosomal system where the antigen processing and binding of antigenic peptides to MHC class II takes place. Serves as cell surface receptor for the cytokine MIF.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Anti-CD74 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
S227928 |
S64315 (MIK665) |
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1) |
Val-Cit-(PEG24) linker |
Anti-hCD74 clone11
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-CD74 ADC 12-13 |
Anti-CD74 ADC 12-13 payload |
Undisclosed |
Anti-CD74 ADC 12-13 linker |
[1] | |
Anti-CD74 ADC 12-14 |
Anti-CD74 ADC 12-14 payload |
Undisclosed |
Anti-CD74 ADC 12-14 linker |
[1] | |
Anti-CD74 ADC 12-15 |
Anti-CD74 ADC 12-15 payload |
Undisclosed |
Anti-CD74 ADC 12-15 linker |
[1] |
Anti-hCD74 LL1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-CD74 ADC 12-4 |
Anti-CD74 ADC 12-4 payload |
Undisclosed |
Anti-CD74 ADC 12-4 linker |
[1] | |
Anti-CD74 ADC 2-7 |
Anti-CD74 ADC 2-7 payload |
Undisclosed |
Anti-CD74 ADC 2-7 linker |
[1] | |
Anti-CD74 ADC 3-4 |
Anti-CD74 ADC 3-4 payload |
Undisclosed |
Anti-CD74 ADC 3-4 linker |
[1] | |
Anti-CD74 ADC 4-3 |
Anti-CD74 ADC 4-3 payload |
Undisclosed |
Anti-CD74 ADC 4-3 linker |
[1] | |
Anti-CD74 ADC 5-3 |
Anti-CD74 ADC 5-3 payload |
Undisclosed |
Anti-CD74 ADC 5-3 linker |
[1] | |
Anti-CD74 ADC 6-2 |
Anti-CD74 ADC 6-2 payload |
Undisclosed |
Anti-CD74 ADC 6-2 linker |
[1] | |
Anti-CD74 ADC 7-1 |
Anti-CD74 ADC 7-1 payload |
Undisclosed |
Anti-CD74 ADC 7-1 linker |
[1] | |
Anti-CD74 ADC 8-5 |
Anti-CD74 ADC 8-5 payload |
Undisclosed |
Anti-CD74 ADC 8-5 linker |
[1] | |
Anti-CD74 ADC 9-4 |
Anti-CD74 ADC 9-4 payload |
Undisclosed |
Anti-CD74 ADC 9-4 linker |
[1] | |
Anti-CD74 ADC 10-1 |
Anti-CD74 ADC 10-1 payload |
Undisclosed |
Anti-CD74 ADC 10-1 linker |
[1] | |
Anti-CD74 ADC 11-5 |
Anti-CD74 ADC 11-5 payload |
Undisclosed |
Anti-CD74 ADC 11-5 linker |
[1] | |
Anti-CD74 ADC 12-3 |
Anti-CD74 ADC 12-3 payload |
Undisclosed |
Anti-CD74 ADC 12-3 linker |
[1] | |
Anti-CD74 ADC 13-7 |
Anti-CD74 ADC 13-7 payload |
Undisclosed |
Anti-CD74 ADC 13-7 linker |
[1] | |
Anti-CD74 ADC 14-5 |
Anti-CD74 ADC 14-5 payload |
Undisclosed |
Anti-CD74 ADC 14-5 linker |
[1] | |
Anti-CD74 ADC 15-5 |
Anti-CD74 ADC 15-5 payload |
Undisclosed |
Anti-CD74 ADC 15-5 linker |
[1] | |
Anti-CD74 ADC 16-5 |
Anti-CD74 ADC 16-5 payload |
Undisclosed |
Anti-CD74 ADC 16-5 linker |
[1] | |
Anti-CD74 ADC 17-2 |
Anti-CD74 ADC 17-2 payload |
Undisclosed |
Anti-CD74 ADC 17-2 linker |
[1] |
Bezetabart
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Bezetabart debotansine |
SC347 |
Microtubule (MT) |
Cys-12 ADC linker |
CD74 Milatuzumab DANAPAE152C S375C
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CD74 Milatuzumab DANAPAE152C S375C-P1-L35-P1 |
P1 payload |
Undisclosed |
L35 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P1-L12-P4 |
P4 payload |
Undisclosed |
L12 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P1-L12-P3 |
P3 payload |
Undisclosed |
L12 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P2-L13-P1 |
P1 payload |
Undisclosed |
L13 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P1-L32-P2 |
P2 payload |
Undisclosed |
L32 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P1-L30-P2 |
P2 payload |
Undisclosed |
L30 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P1-L17-P2 |
P2 payload |
Undisclosed |
L17 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P1-L27-P1 |
P1 payload |
Undisclosed |
L27 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P1-L11-P1 |
P1 payload |
Undisclosed |
L11 linker |
[2] | |
CD74 Milatuzumab DANAPAE152C S375C-P1-L18-P2 |
P2 payload |
Undisclosed |
L18 linker |
[2] |
HuMab-CD74-005
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuMab-CD74-005-vcMMAE |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[3] | |
HuMab-CD74-005-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Undisclosed |
[3] |
HuMab-CD74-006
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuMab-CD74-006-vcMMAE |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[3] | |
HuMab-CD74-006-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Undisclosed |
[3] |
HuMab-CD74-011
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HuMab-CD74-011-vcMMAE |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[3] |
Milatuzumab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Milatuzumab doxorubicin |
Doxorubicin |
DNA topoisomerase 2-alpha (TOP2A) |
SMCC-hydrazide |
||
Milatuzumab-RSL3-NH2 |
RSL3-NH2 |
Phospholipid hydroperoxide glutathione peroxidase (GPX4) |
Mal-PEG4-DBCO-Ala-Val |
[4] | |
HLL1-CL2A-SN38 |
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2A |
[5] |
Undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Antibody-drug conjugate (Ambrx Inc) |
Undisclosed |
Undisclosed |
Undisclosed |
[6] |
References
